Case Report
Accepted on 18 Nov 2024
An intracranial yolk sac tumor with initial symptom of hemorrhage in the basal ganglia: Case Report
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1402819
Type at least 3 characters
29,186 articles
Articles
Original Research
Accepted on 18 Nov 2024
RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1497093
Editorial
Accepted on 18 Nov 2024
Editorial: Women in Breast Cancer Volume III 2023
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1515282
- 101 views
Brief Research Report
Accepted on 18 Nov 2024
The Epidemiology of Pediatric Oncology and Hematopoietic Cell Transplant Admissions to U.S. Intensive Care Units from 2001-2019
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1501977
Editorial
Published on 18 Nov 2024
Editorial: Childhood leukemias in Latin America: epidemiology, causality, novel predictive profiles and therapeutic strategies
in Cancer Epidemiology and Prevention
Frontiers in Oncology
doi 10.3389/fonc.2024.1509943
- 196 views
Case Report
Published on 18 Nov 2024
Case report: Metastatic endocrine mucin-producing sweat gland carcinoma with features of mucinous carcinoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1449270
- 235 views
Case Report
Published on 18 Nov 2024
Case report: Triple-negative breast cancer with low tumour-infiltrating lymphocytes infiltration and good prognosis: a case of Tall Cell Carcinoma with Reversed Polarity and review of the literature
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1455893
- 167 views
Correction
Published on 18 Nov 2024
Corrigendum: Predictive factor of large‐volume central lymph node metastasis in clinical N0 papillary thyroid carcinoma patients underwent total thyroidectomy
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1517682
Systematic Review
Published on 18 Nov 2024
Efficacy and safety of angiogenesis inhibitors combined with poly ADP ribose polymerase inhibitors in the maintenance treatment of advanced ovarian cancer: a meta-analysis
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1477105
- 217 views
Case Report
Published on 18 Nov 2024
Bevacizumab for the treatment of metastatic colorectal cancer complicated by abdominal aortic aneurysm and mural thrombus: a case report
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1416349
- 252 views
Original Research
Published on 18 Nov 2024
Exploration of the value of concurrent chemotherapy for T2N1 nasopharyngeal carcinoma under intensity modulated radiotherapy mode
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1424804
- 135 views
Case Report
Published on 18 Nov 2024
Undifferentiated pleomorphic sarcoma of the adrenal gland: a case report and literature review
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1439357
- 173 views
Original Research
Published on 18 Nov 2024
Aminotransferase-to-lymphocyte ratio as a valuable prognostic marker for patients with stage I-III colorectal cancer: a retrospective study
in Gastrointestinal Cancers: Colorectal Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1446557
- 187 views
Case Report
Published on 18 Nov 2024
Long-term survival in metastatic gastric cancer patient with Apatinib plus S-1 maintenance treatment following first-line chemotherapy—case report
in Gastrointestinal Cancers: Gastric and Esophageal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2024.1478719
- 153 views
Original Research
Accepted on 15 Nov 2024
Comparison of Tracer Kinetic Models in Differentiating Malignant from Normal Prostate Tissue Using Dynamic Contrast-Enhanced MRI
in Cancer Imaging and Image-directed Interventions
Frontiers in Oncology
doi 10.3389/fonc.2024.1450388
Case Report
Accepted on 15 Nov 2024
Bankverbindung Bank für Sozialwirtschaft IBAN DE47 8602 0500 0003 5577 00 BIC BFSWDE33LPZ Klinik für Nephrologie mit KfH Nierenzentrum
in Surgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1422131